Synthesis and investigation on antidiabetic activity of 4-(1-aryl-3-oxo-5-phenylpentylamino) benzenesulfonamide.
- Author:
Da-Cheng YANG
1
;
Ju-Fang YAN
;
Jin XU
;
Fei YE
;
Zu-Wen ZHOU
;
Wei-Yu ZHANG
;
Li FAN
;
Xin CHEN
Author Information
1. School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China. hxydc@swu.edu.cn
- Publication Type:Journal Article
- MeSH:
Drug Design;
Glycoside Hydrolase Inhibitors;
Hypoglycemic Agents;
chemical synthesis;
chemistry;
pharmacology;
Peroxisome Proliferator-Activated Receptors;
agonists;
Structure-Activity Relationship;
Sulfanilamides;
chemistry;
Sulfonamides;
chemical synthesis;
chemistry;
pharmacology;
alpha-Glucosidases;
metabolism
- From:
Acta Pharmaceutica Sinica
2010;45(1):66-71
- CountryChina
- Language:Chinese
-
Abstract:
Searching for new antidiabetic lead compound, 4-(1-aryl-3-oxo-5-phenylpentylamino) benzenesulfonamides were designed and synthesized directly by three component one-pot condensation of 4-phenyl-2-butanone and sulfanilamide with some aromatic aldehydes at an yield of 23%-97%. The chemical structures of the twelve new Mannich bases were confirmed by 1H NMR, 13C NMR, FTIR, ESI-MS and HR-MS. The screening results of antidiabetic activity indicated that most of these title compounds possess alpha-glucosidase inhibitory activity, among which compound le is the strongest one. And compound 11 possesses good peroxisome proliferator-activated receptor response element (PPRE) agonist activity. The structure-activity relationship of these new beta-amino ketones containing benzenesulfonamide unit was also discussed preliminarily.
